Show simple item record

dc.contributor.authorShokraneh, Farhad
dc.date.accessioned2017-09-20T15:53:48Z
dc.date.available2017-09-20T15:53:48Z
dc.date.issued2014
dc.identifier.citationAghayan, H. R., Arjmand, B., Yaghoubi, M., Moradi-Lakeh, M., Kashani, H. & Shokraneh, F. (2014). Clinical outcome of autologous mononuclear cells transplantation for spinal cord injury: A systematic review and meta-analysis. Medical Journal of the Islamic Republic of Iran, 28 (112), pp.112-112.
dc.identifier.urihttp://hdl.handle.net/20.500.12904/6110
dc.description.abstractBackground: Cell-based therapies can be used to treat neurological diseases and spinal cord injuries. The aim of this study was to assess the clinical outcome of bone marrow derived mononuclear cells (BM-MNCs) transplantation in patients with spinal cord injuries.; Methods: Following a systematic review to detect clinical intervention studies, a meta-analysis was done for pooling data to estimate the outcome of BM-MNCs transplantation. The percentage of the patients with improved ASIA scale from one grade to a higher grade was defined as the main outcome. By considering the study design and outcome measurement, two reviewers independently extracted the data.; Results: Eight relevant primary studies were found; seven qualified studies, with a combined total of 328 patients were assessed by meta-analysis, including 314 ASIA-A, 13 ASIA-B, 94 cervical, 227 thoracic and 60 acute injuries. The percentage of the patients' improvement was tested by meta-analysis through random and fixed models. The overall percentage of all patients' improved ASIA scale after a one- year follow-up (95% CIs) was 43 (0.27-0.59).; Conclusion: Data from published trials revealed that encouraging results were achieved by autologous BMMNCs for the treatment of spinal cord injury. However, the number of clinical trials included in the systematic review was too limited to reach a definite conclusion. More qualified clinical trials with standardized methods are needed to truly justify the outcome of this therapeutic modality in SCI patients.;
dc.description.urihttp://mjiri.iums.ac.ir/article-1-2493-en.html&sw=Clinical+Outcome+of+Autologous+Mononuclear+Cells+Transplantation+for+Spinal+Cord+Injury%3A+A+Systematic+Review+and+Meta-Analysis
dc.formatFull text uploaded
dc.subjectSpinal cord injuries
dc.subjectNeurological rehabilitation
dc.titleClinical outcome of autologous mononuclear cells transplantation for spinal cord injury: A systematic review and meta-analysis
dc.typeArticle
refterms.dateFOA2021-06-11T09:00:25Z
html.description.abstractBackground: Cell-based therapies can be used to treat neurological diseases and spinal cord injuries. The aim of this study was to assess the clinical outcome of bone marrow derived mononuclear cells (BM-MNCs) transplantation in patients with spinal cord injuries.; Methods: Following a systematic review to detect clinical intervention studies, a meta-analysis was done for pooling data to estimate the outcome of BM-MNCs transplantation. The percentage of the patients with improved ASIA scale from one grade to a higher grade was defined as the main outcome. By considering the study design and outcome measurement, two reviewers independently extracted the data.; Results: Eight relevant primary studies were found; seven qualified studies, with a combined total of 328 patients were assessed by meta-analysis, including 314 ASIA-A, 13 ASIA-B, 94 cervical, 227 thoracic and 60 acute injuries. The percentage of the patients' improvement was tested by meta-analysis through random and fixed models. The overall percentage of all patients' improved ASIA scale after a one- year follow-up (95% CIs) was 43 (0.27-0.59).; Conclusion: Data from published trials revealed that encouraging results were achieved by autologous BMMNCs for the treatment of spinal cord injury. However, the number of clinical trials included in the systematic review was too limited to reach a definite conclusion. More qualified clinical trials with standardized methods are needed to truly justify the outcome of this therapeutic modality in SCI patients.;


Files in this item

Thumbnail
Name:
Aghayan 2014 1-12.pdf
Size:
4.738Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record